Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
More Evidence Needed For Chiesi’s Ultra Orphan Lamzede, Says NICE
May 24 2018
•
By
Francesca Bruce
NICE not sure Chiesi's Lamzede is cost-effective • Source: Scrip archive
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Rare Diseases
More from Scrip